a small molecule that remains preclinical and not approved
The following is taken from the section, "How should treatment be given", from the peer-reviewed medical-journal article, "The Many Faces of Cobalamin (Vitamin B12) Deficiency": [Start quote] For parenteral therapy in cases of megaloblastic anemia, it has been advised to administer 1000 mg hydroxocobalamin IM twice weekly for a period of 5 weeks, and the dose is reduced to 1000 mg IM every 2 months thereafter
When taken together, these findings highlight the need for caution in assuming that every compound that is produced by the body is good
Some users may also experience itching or a burning sensation upon application, which can be mitigated using the "sandwich method" or buffering tretinoin's absorption by first applying a cream
A vial appearing to have little or no vacuum does not indicate contamination, degradation, loss of purity, or compromised integrity
The active region of TB-500 binds to G-actin monomers, facilitating the reorganization of the cellular cytoskeleton
